Open AccessThe Contrasting Perceptions and the Cause Regarding Patenting Technologies Between Academic Medical Researchers and Pharmaceutical Companies Based in Japan
Author(s) -
Kazunari Sugimitsu,
Yoshinobu Manome
Publication year - 2021
Publication title -
journal of multidisciplinary healthcare
Language(s) - English
Resource type - Journals
ISSN - 1178-2390
DOI - 10.2147/jmdh.s321834
Subject(s) - popularity , commercialization , pharmaceutical industry , apprehension , pharmaceutical sciences , order (exchange) , medical education , marketing , medicine , psychology , business , pharmacology , social psychology , finance , cognitive psychology
The recent trend of pharmaceutical companies commercializing new objects as new drugs based on the findings of academic medical researchers, commonly categorizing them as "academic drug discovery" is increasingly gaining popularity in the pharmaceutical industry. Studies state that academic researchers based in universities have lower motivation to apply for patents. However, none of the studies evaluated the existence and extent of the "motivation for patent" in academic researchers, being lower than that of pharmaceutical companies. This study assesses two hypotheses; H1: academic medical researchers are less likely to believe that the patent system is necessary for pharmaceuticals, and thus have diminished interest in the commercialization of their research findings when compared to those in the pharmaceutical industry, H2: apprehension of the raison d'être of the patent system affects positive impressions on patents among academic medical researchers.